Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 205227
Company: MYLAN
Company: MYLAN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
TEMOZOLOMIDE | TEMOZOLOMIDE | 5MG | CAPSULE;ORAL | Discontinued | None | No | No |
TEMOZOLOMIDE | TEMOZOLOMIDE | 20MG | CAPSULE;ORAL | Discontinued | None | No | No |
TEMOZOLOMIDE | TEMOZOLOMIDE | 100MG | CAPSULE;ORAL | Discontinued | None | No | No |
TEMOZOLOMIDE | TEMOZOLOMIDE | 140MG | CAPSULE;ORAL | Discontinued | None | No | No |
TEMOZOLOMIDE | TEMOZOLOMIDE | 180MG | CAPSULE;ORAL | Discontinued | None | No | No |
TEMOZOLOMIDE | TEMOZOLOMIDE | 250MG | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
06/29/2016 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |